mRNA vaccines are not new but are now receiving far more attention as a result of the COVID-19 pandemic. The success of the Moderna and Pfizer/BioNTech mRNA vaccines and the speed with which they were rolled out was especially notable and holds great promise for other future applications post-pandemic.

Issues of inadequate or missing data collection, and fragmented, incompatible health systems hampered the response to COVID-19 and threaten to do so in future outbreaks. Fortunately, several possible solutions could at least partly remedy this problem.

During their studies of COVID-19 and the organ damage it can cause, experts have learned more about organs themselves, as well as the human immune system and immune responses to pathogens and are devising ways to slow or even reverse the decline in aging immune systems.

Researcher Parisa Naraei details how AI chatbots glean better data and attain fuller analyses, faster insights, and precision answers in the war against COVID-19 and relates the nuts and bolts of crafting these conversational AI apps.

Despite the global devastation and disruption caused by the COVID-19 pandemic, the situation might have been even worse without the help of AI. As the technology continues to grow and develop, it will also undoubtedly prove its worth in public health efforts to prevent potential pandemics, as well as in easing outbreaks that cannot be prevented or contained as easily.